首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of hepatocellular carcinoma

缩写:

ISSN:N/A

e-ISSN:2253-5969

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引953
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaokun Chen,Jiali Xing,Baoluhe Zhang et al. Xiaokun Chen et al.
Background: Hepatocellular carcinoma (HCC) with microvascular invasion (MVI) is associated with high recurrence risk after curative resection. While adjuvant immune checkpoint inhibitors (ICIs) have shown potential in imp...
Ahmed Attia,Esam Ali Elshimi,Zeinab Mohamed Seif Eldin et al. Ahmed Attia et al.
Background: Predicting the prognosis of patients with HCC is challenging. Aim: To evaluate the Assessment for Retreatment with TACE (AR...
Ching-Tso Chen,Chien-Huai Chuang,Chih-Hung Hsu et al. Ching-Tso Chen et al.
Background and aims: Early alpha-fetoprotein (AFP) response has been reported to predict the treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced hepatocellular carcinoma (HCC). We evaluated...
Ningning Lu,Zhixia Gu,Xiaoxue Yuan et al. Ningning Lu et al.
Background: Inflammation drives tumor development, with neutrophil extracellular traps (NETs) promoting progression through metastasis, immune suppression, and microenvironment modulation. However, the role of NETs-relate...
Wei-Fan Hsu,Ching-Chu Lo,Kuo-Chih Tseng et al. Wei-Fan Hsu et al.
Purpose: The predictors of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC) and a sustained virologic response after direct-acting antiviral therapy are not well known. ...
Xiaohang Lu,Yunyong Wang,Yuan Yu et al. Xiaohang Lu et al.
Background: Hepatocellular carcinoma (HCC) is characterized by high incidence and mortality rates, with hypoxia and anoikis resistance playing crucial roles in its progression and metastasis. While long non-coding RNA (ln...
Junjie Liu,Tong Yuan,Xing Lv et al. Junjie Liu et al.
Background: Cytokeratin 19 (CK19) serves as a significant prognostic indicator for hepatocellular carcinoma (HCC). However, it is uncertain if CK19 expression influences the prognosis and effectiveness of treatment in pat...
Jinlian Che,Yidi Chen,Zhiming Zeng et al. Jinlian Che et al.
Background: Immunotherapy combined with targeted therapy is a key approach for patients with unresectable hepatocellular carcinoma (HCC). This study aimed to evaluate the prognostic value of clinical and CT features in Ca...
Yao Chen,Yanan Zhao,Weiwei Guan et al. Yao Chen et al.
Purpose: Develop a magnetic resonance imaging (MRI)-based deep learning (DL)-radiomics (Rad)-clinical nomogram for predicting early recurrence of hepatocellular carcinoma (HCC) within six months after thermal ablation. ...
Han Yang,Juan Zhao,Yingwei Wang et al. Han Yang et al.
Purpose: This research constructs a prognostic model for overall survival (OS) in hepatocellular carcinoma (HCC) patients using radiomic features from non-contrast CT scans obtained within 24 hours after transarterial che...